R M Egeler1, M E Nesbit. Show Affiliations » 1. Erasmus University of Rotterdam, Sophia Children's Hospital/Dijkzigt Hospital, Department of Pediatrics, The Netherlands.
Abstract
Mesh： See more » AdolescentAdultAgedBone and Bones/pathologyChildChild, PreschoolClinical Trials as TopicCytokines/physiologyFemaleGrowth Substances/physiologyHistiocytosis/classificationHistiocytosis/pathologyHistiocytosis, Langerhans-Cell/classificationHistiocytosis, Langerhans-Cell/epidemiologyHistiocytosis, Langerhans-Cell/etiologyHistiocytosis, Langerhans-Cell/pathologyHistiocytosis, Langerhans-Cell/therapyHumansIncidenceInfantInfant, NewbornLeukemia, Monocytic, Acute/pathologyLymphoma, Large B-Cell, Diffuse/pathologyMaleMiddle AgedMulticenter Studies as TopicPhagocytes/pathologyPrognosisSkin/pathologyViscera/pathology
Substances： See more » CytokinesGrowth Substances
Year: 1995 PMID： 7695824 DOI： 10.1016/1040-8428(94)00117-c
Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN： 1040-8428 Impact factor: 6.312